Eric Bloemer, MD
Family Medicine · Teutopolis, ILNPI 1073742664
Payments from drug & device makers
Across 81 payments — averaging $17.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$255
- Amgen$176
- Lilly USA, LLC$175
- Boehringer Ingelheim$134
- Organon$123
- Johnson & Johnson$110
- plus $478 from 15 others
What the payments were for
- Food & beverage$1,452100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 16 | $255 |
| Amgen | 5 | $176 |
| Lilly USA, LLC | 11 | $175 |
| Boehringer Ingelheim | 8 | $134 |
| Organon | 2 | $123 |
| Johnson & Johnson | 6 | $110 |
| AstraZeneca | 6 | $78 |
| Sanofi-aventis U.S. LLC | 4 | $62 |
| Mylan Specialty L.p. | 4 | $55 |
| Esperion Therapeutics, Inc. | 2 | $41 |
| Merck | 3 | $41 |
| Pfizer | 3 | $40 |
| Xeris Pharmaceuticals, Inc. | 2 | $35 |
| Novartis | 2 | $29 |
| Daiichi Sankyo Inc. | 1 | $16 |
| Dexcom, Inc. | 1 | $16 |
| Sunovion Pharmaceuticals Inc. | 1 | $14 |
| Amarin Pharma, Inc. | 1 | $14 |
| Supernus Pharmaceuticals, Inc. | 1 | $14 |
| Apria Healthcare LLC | 1 | $13 |
| AbbVie | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,452 in reported general payments places this provider in the 75th percentile of 4,116 family medicine providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 645 | $426,093 |
| MounjaroTirzepatide | 104 | $117,216 |
| XareltoRivaroxaban | 131 | $111,349 |
| JanuviaSitagliptin Phosphate | 148 | $108,413 |
| OzempicSemaglutide | 100 | $108,292 |
| JardianceEmpagliflozin | 121 | $85,251 |
| TrulicityDulaglutide | 76 | $78,639 |
| Tresiba Flextouch U-200Insulin Degludec | 45 | $43,813 |
| ProliaDenosumab | 25 | $43,374 |
| EntrestoSacubitril/Valsartan | 55 | $35,012 |
| TradjentaLinagliptin | 30 | $30,032 |
| FarxigaDapagliflozin Propanediol | 29 | $24,443 |
| Humalog Kwikpen U-100Insulin Lispro | 48 | $18,028 |
| ShingrixVaricella-Zoster Ge/As01b/Pf | 77 | $16,155 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 105 | $15,048 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $40 | $426,093645 claims |
| Lilly USA, LLCMounjaro, Trulicity | $175 | $195,856180 claims |
| MerckJanuvia, Dulera, Janumet | $41 | $131,131205 claims |
| Boehringer IngelheimJardiance, Tradjenta, Spiriva Respimat | $134 | $122,340165 claims |
| Novo NordiskOzempic, Rybelsus | $255 | $119,839112 claims |
| Johnson & JohnsonXarelto | $110 | $111,349131 claims |
| AmgenProlia | $176 | $43,37425 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $78 | $37,71166 claims |
| NovartisEntresto | $29 | $35,01255 claims |
| AbbVieLinzess, Creon | $12 | $24,39263 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 4,116 family medicine providers in Illinois.
Other family medicine in Teutopolis
- Daniel BruneCreve Coeur$15M
- Ali BajwaSpringfield$5.8M
- John ElsenEvergreen Park$5M
- Manohar JethaniBerwyn$4.9M
- Tiffany NguyenSkokie$3.9M
- Bradley TorphyChicago$3M
- Diana WidicusRochester$2.6M
- Nicholas WeberEureka$2.5M
- Stanley KochMorton$2.3M
- Mark ChristensenNew Lenox$2.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.